SPX3,821.88+0.33 0.01%
DIA310.40+1.06 0.34%
IXIC11,169.50-12.04 -0.11%

Roth Capital Initiates Coverage On Mydecine Innovations with Buy Rating, Announces Price Target of C$3

Roth Capital analyst Elemer Piros initiates coverage on Mydecine Innovations (NEO: MYCO) with a Buy rating and announces Price Target of C$3.

Benzinga · 06/22/2021 09:03
Roth Capital analyst Elemer Piros initiates coverage on Mydecine Innovations (NEO: MYCO) with a Buy rating and announces Price Target of C$3.